PL1787658T3 - Formulacje o przedłużonym uwalnianiu analogów somatostatyny będących inhibitorami hormonu wzrostu - Google Patents
Formulacje o przedłużonym uwalnianiu analogów somatostatyny będących inhibitorami hormonu wzrostuInfo
- Publication number
- PL1787658T3 PL1787658T3 PL05077559T PL05077559T PL1787658T3 PL 1787658 T3 PL1787658 T3 PL 1787658T3 PL 05077559 T PL05077559 T PL 05077559T PL 05077559 T PL05077559 T PL 05077559T PL 1787658 T3 PL1787658 T3 PL 1787658T3
- Authority
- PL
- Poland
- Prior art keywords
- growth hormone
- somatostatin analogue
- sustained release
- release formulations
- analogue inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05077559A EP1787658B1 (en) | 2005-11-10 | 2005-11-10 | Sustained release formulations of somatostatin analogue inhibitors of growth hormone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1787658T3 true PL1787658T3 (pl) | 2012-08-31 |
Family
ID=35840709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05077559T PL1787658T3 (pl) | 2005-11-10 | 2005-11-10 | Formulacje o przedłużonym uwalnianiu analogów somatostatyny będących inhibitorami hormonu wzrostu |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1787658B1 (pl) |
| AT (1) | ATE549011T1 (pl) |
| CY (1) | CY1112857T1 (pl) |
| DK (1) | DK1787658T3 (pl) |
| ES (1) | ES2383303T3 (pl) |
| PL (1) | PL1787658T3 (pl) |
| PT (1) | PT1787658E (pl) |
| SI (1) | SI1787658T1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0602639D0 (en) * | 2006-02-09 | 2006-03-22 | Novartis Ag | Organic compounds |
| CN101883785B (zh) * | 2007-12-03 | 2014-01-15 | 意大利法尔马科有限公司 | 新的非选择性生长抑素类似物 |
| ITUB20160416A1 (it) * | 2016-01-28 | 2017-07-28 | Italfarmaco Spa | Uso di una formulazione a lento rilascio di octreotide per la prevenzione della formazione di seroma |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3045135A1 (de) | 1980-11-29 | 1982-06-09 | Sandoz-Patent-GmbH, 7850 Lörrach | Pharmazeutische kompositionen enthaltende bioabbaubare polymere |
| FR2537980B1 (fr) | 1982-12-17 | 1986-12-19 | Sandoz Sa | Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation |
| GB8318552D0 (en) | 1983-07-08 | 1983-08-10 | Sandoz Ltd | Organic compounds |
| HU198626B (en) | 1986-05-27 | 1989-11-28 | Sandoz Ag | Process for producing pharmaceutical compositions comprising somatostatin analogues as active ingredient |
| GB2193891B (en) | 1986-08-18 | 1990-07-25 | Sandoz Ltd | Nasal pharmaceutical composition containing a somatostatin anologue. |
| HU906340D0 (en) | 1986-10-13 | 1991-04-29 | Sandoz Ag | Synthesis in solid phase for producing peptonic alcohols |
| DE3845000C2 (de) | 1987-07-10 | 1998-11-19 | Novartis Ag | Anwendung von Octreotid zur Behandlung von Brustkrebs |
| US5538739A (en) | 1989-07-07 | 1996-07-23 | Sandoz Ltd. | Sustained release formulations of water soluble peptides |
| MY108621A (en) | 1990-08-01 | 1996-10-31 | Novartis Ag | Polylactide preparation and purification |
| GB9206736D0 (en) | 1992-03-27 | 1992-05-13 | Sandoz Ltd | Improvements of organic compounds and their use in pharmaceutical compositions |
| SI9300468A (en) | 1992-10-14 | 1994-06-30 | Hoffmann La Roche | Injectable composition for the sustained release of biologically active compounds |
| WO1994008610A1 (en) | 1992-10-16 | 1994-04-28 | Smithkline Beecham Corporation | Pharmaceutical emulsion compositions |
| WO1995000126A1 (en) | 1993-06-22 | 1995-01-05 | Sandoz Ltd. | Surface-modified albumin microspheres and pharmaceutical compositions containing them |
| IL110787A0 (en) | 1993-08-27 | 1994-11-11 | Sandoz Ag | Biodegradable polymer, its preparation and pharmaceutical composition containing it |
| DE69719320T2 (de) | 1996-06-11 | 2003-12-11 | Novartis Ag | Kombination eines somatostatin analogs und eines rapamycins |
| ATE272394T1 (de) | 1996-10-31 | 2004-08-15 | Takeda Chemical Industries Ltd | Zubereitung mit verzögerter freisetzung |
| CA2306090A1 (en) * | 1997-10-24 | 1999-05-06 | Christopher W. Mcdaniel | Delivery vehicles for bioactive agents and uses thereof |
| GB2331924A (en) | 1997-12-08 | 1999-06-09 | Phares Pharm Res Nv | Lipid compositions and their use |
| ATE260674T1 (de) * | 1998-08-17 | 2004-03-15 | Pfizer Prod Inc | Stabilisierte proteinzusammensetzung |
| US6159935A (en) | 1999-11-29 | 2000-12-12 | Pharmacia & Upjohn Co. | Method for preventing diarrhea |
| IT1318539B1 (it) | 2000-05-26 | 2003-08-27 | Italfarmaco Spa | Composizioni farmaceutiche a rilascio prolungato per lasomministrazione parenterale di sostanze idrofile biologicamente |
| WO2002009739A1 (en) | 2000-07-27 | 2002-02-07 | Novartis Ag | Treatment of ocular disorders with somatostatin analogues |
| US20030049320A1 (en) * | 2000-12-18 | 2003-03-13 | Wockhardt Limited | Novel in-situ forming controlled release microcarrier delivery system |
| KR101121675B1 (ko) | 2002-04-19 | 2012-03-13 | 노파르티스 아게 | 신규 생체적합물질, 그의 제조방법 및 용도 |
| US20040097419A1 (en) | 2002-11-19 | 2004-05-20 | Holger Petersen | Organic compounds |
| GB0228571D0 (en) | 2002-12-06 | 2003-01-15 | Novartis Ag | Organic compounds |
-
2005
- 2005-11-10 DK DK05077559.2T patent/DK1787658T3/da active
- 2005-11-10 PT PT05077559T patent/PT1787658E/pt unknown
- 2005-11-10 SI SI200531534T patent/SI1787658T1/sl unknown
- 2005-11-10 EP EP05077559A patent/EP1787658B1/en active Active
- 2005-11-10 ES ES05077559T patent/ES2383303T3/es active Active
- 2005-11-10 AT AT05077559T patent/ATE549011T1/de active
- 2005-11-10 PL PL05077559T patent/PL1787658T3/pl unknown
-
2012
- 2012-06-11 CY CY20121100528T patent/CY1112857T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE549011T1 (de) | 2012-03-15 |
| EP1787658B1 (en) | 2012-03-14 |
| EP1787658A1 (en) | 2007-05-23 |
| PT1787658E (pt) | 2012-06-22 |
| ES2383303T3 (es) | 2012-06-20 |
| DK1787658T3 (da) | 2012-06-25 |
| CY1112857T1 (el) | 2016-04-13 |
| SI1787658T1 (sl) | 2012-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2416280T3 (es) | Composición cosmética adelgazante a base de L-arginina o de uno de sus derivados | |
| AP2397A (en) | Matrix for sustained, invariant and independent release of active compounds. | |
| JP2003534265A5 (pl) | ||
| ATE413865T1 (de) | Zusammensetzungen mit alphahydroxy-säureester zur wirkstofffreisetzung und anwendungsverfahren dafür | |
| ES2195798T1 (es) | Formulacion para mujeres menopausicas. | |
| CA2248955A1 (en) | The use of fumaric acid derivatives | |
| WO2003013497A1 (fr) | Compositions s'averant efficaces pour prevenir ou soulager des troubles ou maladies provoques par une hypofonction cerebrale | |
| DE60000133D1 (de) | Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen | |
| BR0209320A (pt) | ésteres de uridina farmaceuticamente ativos | |
| NZ610465A (en) | Clevidipine emulsion formulations containing antimicrobial agents | |
| NO20014719L (no) | Orale farmasöytiske preparater inneholdende lang-kjedete triglyserider og lipofile overflateaktive midler | |
| CL2011001225A1 (es) | Formulacion farmaceutica en solucion acuosa que comprende desde 1% hasta 5% (p/v) de una sal de diclofenaco, desde 3% hasta 30% (p/v) de al menos un polioxialquilen ester de hidroxido de acido graso y un co-solvente seleccionado de etanol, propanol, glicerol, propilenglicol entre otros. | |
| CY1112857T1 (el) | Φαρμακοτεχνικες μορφες παρατεταμενης απελευθερωσης αναλογου σωματοστατινης αναστολεων αναπτυξης ορμονης | |
| MX2009012782A (es) | Formulaciones para administracion oral de agentes terapeuticos y metodos relacionados. | |
| WO2008093772A1 (ja) | 経皮または経粘膜投与のためのアジュバントおよびこれを含む医薬製剤 | |
| GEP20053455B (en) | Pharmaceutical Preparations | |
| UY26303A1 (es) | Composiciones farmacéuticas para administración oral y tópica | |
| MX2007006775A (es) | Composiciones estables de fenofibrato con esteres de acido graso. | |
| FR2722410B1 (fr) | Procede de stabilisation des acides gras poly-insatures et utilisation de ces produits stabilises entherapeutique | |
| RS52735B (en) | APPLICATION OF A COMBINATION CONTAINING L-CARNITINE OR ALKANOIL L-CARNITINE, OIL-SOLUBLE OIL-BENZOQUINON AND OMEGA-3-POLYESATURATED FATTY ACID FOR PREPARATION OF NUTRITION OR MEDICINAL PRODUCTS | |
| NO20024796L (no) | Preparater for anvendelse som penetrasjonsfremmere i transdermale formuleringer for meget lipofile aktive bestanddeler | |
| NO20072332L (no) | Lerkanidipinkapsler | |
| JP5048372B2 (ja) | 育毛促進剤 | |
| ATE462418T1 (de) | Stabile pharmazeutische zubereitungen zur kontrollierten freisetzung von fenofibrat and pravastatin | |
| CA2494503A1 (en) | Treatment of multiple sclerosis with brain targeted anti oxidant compounds |